Cargando…

A biologically active peptide mimetic of N-acetylgalactosamine/galactose

BACKGROUND: Glycosylated proteins and lipids are important regulatory factors whose functions can be altered by addition or removal of sugars to the glycan structure. The glycans are recognized by sugar-binding lectins that serve as receptors on the surface of many cells and facilitate initiation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggink, Laura L, Hoober, J Kenneth
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657794/
https://www.ncbi.nlm.nih.gov/pubmed/19284521
http://dx.doi.org/10.1186/1756-0500-2-23
_version_ 1782165616633839616
author Eggink, Laura L
Hoober, J Kenneth
author_facet Eggink, Laura L
Hoober, J Kenneth
author_sort Eggink, Laura L
collection PubMed
description BACKGROUND: Glycosylated proteins and lipids are important regulatory factors whose functions can be altered by addition or removal of sugars to the glycan structure. The glycans are recognized by sugar-binding lectins that serve as receptors on the surface of many cells and facilitate initiation of an intracellular signal that changes the properties of the cells. We identified a peptide that mimics the ligand of an N-acetylgalactosamine (GalNAc)-specific lectin and asked whether the peptide would express specific biological activity. FINDINGS: A 12-mer phage display library was screened with a GalNAc-specific lectin to identify an amino acid sequence that binds to the lectin. Phage particles that were eluted from the lectin with free GalNAc were considered to have been bound to a GalNAc-binding site. Peptides were synthesized with the selected sequence as a quadravalent structure to facilitate receptor crosslinking. Treatment of human peripheral blood mononuclear cells for 24 h with the peptide stimulated secretion of interleukin-8 (IL-8) but not of IL-1β, IL-6, IL-10, or tumor necrosis factor-α (TNF-α). The secretion of IL-21 was stimulated as strongly with the peptide as with interferon-γ. CONCLUSION: The data indicate that the quadravalent peptide has biological activity with a degree of specificity. These effects occurred at concentrations in the nanomolar range, in contrast to free sugars that generally bind to proteins in the micro- to millimolar range.
format Text
id pubmed-2657794
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26577942009-03-19 A biologically active peptide mimetic of N-acetylgalactosamine/galactose Eggink, Laura L Hoober, J Kenneth BMC Res Notes Short Report BACKGROUND: Glycosylated proteins and lipids are important regulatory factors whose functions can be altered by addition or removal of sugars to the glycan structure. The glycans are recognized by sugar-binding lectins that serve as receptors on the surface of many cells and facilitate initiation of an intracellular signal that changes the properties of the cells. We identified a peptide that mimics the ligand of an N-acetylgalactosamine (GalNAc)-specific lectin and asked whether the peptide would express specific biological activity. FINDINGS: A 12-mer phage display library was screened with a GalNAc-specific lectin to identify an amino acid sequence that binds to the lectin. Phage particles that were eluted from the lectin with free GalNAc were considered to have been bound to a GalNAc-binding site. Peptides were synthesized with the selected sequence as a quadravalent structure to facilitate receptor crosslinking. Treatment of human peripheral blood mononuclear cells for 24 h with the peptide stimulated secretion of interleukin-8 (IL-8) but not of IL-1β, IL-6, IL-10, or tumor necrosis factor-α (TNF-α). The secretion of IL-21 was stimulated as strongly with the peptide as with interferon-γ. CONCLUSION: The data indicate that the quadravalent peptide has biological activity with a degree of specificity. These effects occurred at concentrations in the nanomolar range, in contrast to free sugars that generally bind to proteins in the micro- to millimolar range. BioMed Central 2009-02-11 /pmc/articles/PMC2657794/ /pubmed/19284521 http://dx.doi.org/10.1186/1756-0500-2-23 Text en Copyright © 2009 Eggink et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Eggink, Laura L
Hoober, J Kenneth
A biologically active peptide mimetic of N-acetylgalactosamine/galactose
title A biologically active peptide mimetic of N-acetylgalactosamine/galactose
title_full A biologically active peptide mimetic of N-acetylgalactosamine/galactose
title_fullStr A biologically active peptide mimetic of N-acetylgalactosamine/galactose
title_full_unstemmed A biologically active peptide mimetic of N-acetylgalactosamine/galactose
title_short A biologically active peptide mimetic of N-acetylgalactosamine/galactose
title_sort biologically active peptide mimetic of n-acetylgalactosamine/galactose
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657794/
https://www.ncbi.nlm.nih.gov/pubmed/19284521
http://dx.doi.org/10.1186/1756-0500-2-23
work_keys_str_mv AT egginklaural abiologicallyactivepeptidemimeticofnacetylgalactosaminegalactose
AT hooberjkenneth abiologicallyactivepeptidemimeticofnacetylgalactosaminegalactose
AT egginklaural biologicallyactivepeptidemimeticofnacetylgalactosaminegalactose
AT hooberjkenneth biologicallyactivepeptidemimeticofnacetylgalactosaminegalactose